Therefore, we here used a model of transient focal cerebral ischemia, which is known to be associated with inflammatory processes, in genetically altered mice to explore the impact of QC, isoQC and CCL2 expression in experimental stroke, as well as the consequences of the genetic ablation on the functional outcome, infarct volumes, the reactions of diverse cell types and biochemical consequences. Here, CCL2 is linked to stroke disorder.